{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:05:27Z","timestamp":1774278327574,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11657-020-00749-w","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T21:04:25Z","timestamp":1590527065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early changes in bone turnover predict longer-term changes in bone mineral density but not trabecular bone score in frail older women"],"prefix":"10.1007","volume":"15","author":[{"given":"Mary P.","family":"Kotlarczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subashan","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil M.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Nace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"issue":"10","key":"749_CR1","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis F (2014) Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381. https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"issue":"4 Suppl 1","key":"749_CR2","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.amjmed.2005.12.020","volume":"119","author":"SL Bonnick","year":"2006","unstructured":"Bonnick SL, Shulman L (2006) Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? Am J Med 119(4 Suppl 1):S25\u2013S31. https:\/\/doi.org\/10.1016\/j.amjmed.2005.12.020","journal-title":"Am J Med"},{"key":"749_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2019.9372","volume":"322","author":"DC Bauer","year":"2019","unstructured":"Bauer DC (2019) Clinical use of bone turnover markers. JAMA. 322:569. https:\/\/doi.org\/10.1001\/jama.2019.9372","journal-title":"JAMA."},{"issue":"4","key":"749_CR4","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1210\/jc.2005-1712","volume":"91","author":"DC Bauer","year":"2006","unstructured":"Bauer DC, Garnero P, Bilezikian JP, Greenspan SL, Ensrud KE, Rosen CJ, Palermo L, Black DM (2006) Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 91(4):1370\u20131375. https:\/\/doi.org\/10.1210\/jc.2005-1712","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"749_CR5","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1210\/jc.2004-1091","volume":"90","author":"SL Greenspan","year":"2005","unstructured":"Greenspan SL, Resnick NM, Parker RA (2005) Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial. J Clin Endocrinol Metab 90(5):2762\u20132767. https:\/\/doi.org\/10.1210\/jc.2004-1091","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"749_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00198-013-2426-2","volume":"25","author":"R Niimi","year":"2014","unstructured":"Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Nakamura T, Kono T, Sudo A (2014) An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide. Osteoporos Int 25(1):377\u2013384. https:\/\/doi.org\/10.1007\/s00198-013-2426-2","journal-title":"Osteoporos Int"},{"issue":"4","key":"749_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1210\/jc.2008-1122","volume":"94","author":"SM Burnett-Bowie","year":"2009","unstructured":"Burnett-Bowie SM, Saag K, Sebba A, de Papp AE, Chen E, Rosenberg E, Greenspan SL (2009) Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates. J Clin Endocrinol Metab 94(4):1097\u20131103. https:\/\/doi.org\/10.1210\/jc.2008-1122","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"749_CR8","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1359\/JBMR.040512","volume":"19","author":"DC Bauer","year":"2004","unstructured":"Bauer DC, Black DM, Garnero P, Hochberg M, Ott S, Orloff J, Thompson DE, Ewing SK, Delmas PD, Fracture Intervention Trial Study G (2004) Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res 19(8):1250\u20131258. https:\/\/doi.org\/10.1359\/JBMR.040512","journal-title":"J Bone Miner Res"},{"issue":"6","key":"749_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","volume":"18","author":"R Eastell","year":"2003","unstructured":"Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD (2003) Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 18(6):1051\u20131056. https:\/\/doi.org\/10.1359\/jbmr.2003.18.6.1051","journal-title":"J Bone Miner Res"},{"issue":"4","key":"749_CR10","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","volume":"87","author":"MC Hochberg","year":"2002","unstructured":"Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD (2002) Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87(4):1586\u20131592. https:\/\/doi.org\/10.1210\/jcem.87.4.8415","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"749_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/jbmr.1644","volume":"27","author":"RM Jacques","year":"2012","unstructured":"Jacques RM, Boonen S, Cosman F, Reid IR, Bauer DC, Black DM, Eastell R (2012) Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 27(8):1627\u20131634. https:\/\/doi.org\/10.1002\/jbmr.1644","journal-title":"J Bone Miner Res"},{"issue":"6","key":"749_CR12","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00198-018-4468-y","volume":"29","author":"J Aleksova","year":"2018","unstructured":"Aleksova J, Kurniawan S, Elder GJ (2018) The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease. Osteoporos Int 29(6):1447\u20131455. https:\/\/doi.org\/10.1007\/s00198-018-4468-y","journal-title":"Osteoporos Int"},{"issue":"6","key":"749_CR13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jamainternmed.2015.0747","volume":"175","author":"SL Greenspan","year":"2015","unstructured":"Greenspan SL, Perera S, Ferchak MA, Nace DA, Resnick NM (2015) Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial. JAMA Intern Med 175(6):913\u2013921. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0747","journal-title":"JAMA Intern Med"},{"issue":"3","key":"749_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1385\/jcd:2:3:275","volume":"2","author":"LF Varney","year":"1999","unstructured":"Varney LF, Parker RA, Vincelette A, Greenspan SL (1999) Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis. J Clin Densitom 2(3):275\u2013283. https:\/\/doi.org\/10.1385\/jcd:2:3:275","journal-title":"J Clin Densitom"},{"issue":"1","key":"749_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12018-016-9203-7","volume":"14","author":"N Binkley","year":"2016","unstructured":"Binkley N, Leslie WD (2016) Clinical application of spine trabecular bone score (TBS). Clinical Reviews in Bone and Mineral Metabolism 14(1):14\u201325. https:\/\/doi.org\/10.1007\/s12018-016-9203-7","journal-title":"Clinical Reviews in Bone and Mineral Metabolism"},{"issue":"3","key":"749_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jocd.2017.06.019","volume":"20","author":"E Shevroja","year":"2017","unstructured":"Shevroja E, Lamy O, Kohlmeier L, Koromani F, Rivadeneira F, Hans D (2017) Use of trabecular bone score (TBS) as a complementary approach to dual-energy X-ray absorptiometry (DXA) for fracture risk assessment in clinical practice. J Clin Densitom 20(3):334\u2013345. https:\/\/doi.org\/10.1016\/j.jocd.2017.06.019","journal-title":"J Clin Densitom"},{"issue":"3","key":"749_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jocd.2011.05.005","volume":"14","author":"D Hans","year":"2011","unstructured":"Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA (2011) Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom 14(3):302\u2013312. https:\/\/doi.org\/10.1016\/j.jocd.2011.05.005","journal-title":"J Clin Densitom"},{"issue":"3","key":"749_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jocd.2012.05.001","volume":"16","author":"R Winzenrieth","year":"2013","unstructured":"Winzenrieth R, Michelet F, Hans D (2013) Three-dimensional (3D) microarchitecture correlations with 2D projection image gray-level variations assessed by trabecular bone score using high-resolution computed tomographic acquisitions: effects of resolution and noise. J Clin Densitom 16(3):287\u2013296. https:\/\/doi.org\/10.1016\/j.jocd.2012.05.001","journal-title":"J Clin Densitom"},{"issue":"9321","key":"749_CR19","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","volume":"359","author":"JA Kanis","year":"2002","unstructured":"Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359(9321):1929\u20131936. https:\/\/doi.org\/10.1016\/S0140-6736(02)08761-5","journal-title":"Lancet"},{"key":"749_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","volume":"185","author":"S Katz","year":"1963","unstructured":"Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The Index of Adl: A Standardized Measure of Biological and Psychosocial Function. JAMA 185:914\u2013919","journal-title":"JAMA"},{"issue":"3","key":"749_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179\u2013186","journal-title":"Gerontologist"},{"issue":"2","key":"749_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cger.2010.02.002","volume":"26","author":"G Abellan van Kan","year":"2010","unstructured":"Abellan van Kan G, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B (2010) The assessment of frailty in older adults. Clin Geriatr Med 26(2):275\u2013286. https:\/\/doi.org\/10.1016\/j.cger.2010.02.002","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"749_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jama.2010.1923","volume":"305","author":"S Studenski","year":"2011","unstructured":"Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J (2011) Gait speed and survival in older adults. JAMA 305(1):50\u201358. https:\/\/doi.org\/10.1001\/jama.2010.1923","journal-title":"JAMA"},{"issue":"10","key":"749_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1532-5415.1975.tb00927.x","volume":"23","author":"E Pfeiffer","year":"1975","unstructured":"Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 23(10):433\u2013441","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"749_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1191\/0269215502cr515oa","volume":"16","author":"SK Rigler","year":"2002","unstructured":"Rigler SK, Studenski S, Wallace D, Reker DM, Duncan PW (2002) Co-morbidity adjustment for functional outcomes in community-dwelling older adults. Clin Rehabil 16(4):420\u2013428","journal-title":"Clin Rehabil"},{"issue":"3","key":"749_CR26","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, MA MB, Cardiovascular Health Study Collaborative Research G (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146\u2013M156","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"749_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/geront\/41.5.671","volume":"41","author":"EF Binder","year":"2001","unstructured":"Binder EF, Miller JP, Ball LJ (2001) Development of a test of physical performance for the nursing home setting. Gerontologist 41(5):671\u2013679","journal-title":"Gerontologist"},{"key":"749_CR28","doi-asserted-by":"publisher","first-page":"115158","DOI":"10.1016\/j.bone.2019.115158","volume":"131","author":"F Gossiel","year":"2019","unstructured":"Gossiel F, Paggiosi MA, Naylor KE, McCloskey EV, Walsh J, Peel N, Eastell R (2019) The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: the T-score bone marker approach in the TRIO study. Bone 131:115158. https:\/\/doi.org\/10.1016\/j.bone.2019.115158","journal-title":"Bone"},{"issue":"9","key":"749_CR29","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","volume":"13","author":"SL Greenspan","year":"1998","unstructured":"Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 13(9):1431\u20131438. https:\/\/doi.org\/10.1359\/jbmr.1998.13.9.1431","journal-title":"J Bone Miner Res"},{"issue":"10","key":"749_CR30","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 11(10):1531\u20131538. https:\/\/doi.org\/10.1002\/jbmr.5650111021","journal-title":"J Bone Miner Res"},{"issue":"9","key":"749_CR31","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/jbmr.2847","volume":"31","author":"KJ Bell","year":"2016","unstructured":"Bell KJ, Hayen A, Glasziou P, Irwig L, Eastell R, Harrison SL, Black DM, Bauer DC (2016) Potential usefulness of BMD and bone turnover monitoring of zoledronic acid therapy among women with osteoporosis: secondary analysis of randomized controlled trial data. J Bone Miner Res 31(9):1767\u20131773. https:\/\/doi.org\/10.1002\/jbmr.2847","journal-title":"J Bone Miner Res"},{"key":"749_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bone.2016.11.009","volume":"95","author":"JN Tsai","year":"2017","unstructured":"Tsai JN, Burnett-Bowie SM, Lee H, Leder BZ (2017) Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study. Bone 95:20\u201325. https:\/\/doi.org\/10.1016\/j.bone.2016.11.009","journal-title":"Bone"},{"issue":"3","key":"749_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00198-018-04819-1","volume":"30","author":"R Eastell","year":"2019","unstructured":"Eastell R, Mitlak BH, Wang Y, Hu M, Fitzpatrick LA, Black DM (2019) Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE. Osteoporos Int 30(3):667\u2013673. https:\/\/doi.org\/10.1007\/s00198-018-04819-1","journal-title":"Osteoporos Int"},{"issue":"5","key":"749_CR34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s001980070111","volume":"11","author":"NE Lane","year":"2000","unstructured":"Lane NE, Sanchez S, Genant HK, Jenkins DK, Arnaud CD (2000) Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporos Int 11(5):434\u2013442. https:\/\/doi.org\/10.1007\/s001980070111","journal-title":"Osteoporos Int"},{"issue":"3","key":"749_CR35","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00198-012-2155-y","volume":"24","author":"MA Krieg","year":"2013","unstructured":"Krieg MA, Aubry-Rozier B, Hans D, Leslie WD, Manitoba Bone Density P (2013) Effects of anti-resorptive agents on trabecular bone score (TBS) in older women. Osteoporos Int 24(3):1073\u20131078. https:\/\/doi.org\/10.1007\/s00198-012-2155-y","journal-title":"Osteoporos Int"},{"issue":"2","key":"749_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1681\/ASN.2018060656","volume":"30","author":"IDB Marques","year":"2019","unstructured":"Marques IDB, Araujo M, Graciolli FG, Dos Reis LM, Pereira RMR, Alvarenga JC, Custodio MR, Jorgetti V, Elias RM, Moyses RMA, David-Neto E (2019) A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation. J Am Soc Nephrol 30(2):355\u2013365. https:\/\/doi.org\/10.1681\/ASN.2018060656","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"749_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1359\/jbmr.070906","volume":"23","author":"RR Recker","year":"2008","unstructured":"Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, Garcia-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF (2008) Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 23(1):6\u201316. https:\/\/doi.org\/10.1359\/jbmr.070906","journal-title":"J Bone Miner Res"},{"issue":"6","key":"749_CR38","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/s8756-3282(02)00728-7","volume":"30","author":"JA Clowes","year":"2002","unstructured":"Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R (2002) Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 30(6):886\u2013890. https:\/\/doi.org\/10.1016\/s8756-3282(02)00728-7","journal-title":"Bone"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-020-00749-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-020-00749-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-020-00749-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T23:32:25Z","timestamp":1621985545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-020-00749-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s11657-020-00749-w","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]},"assertion":[{"value":"6 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mary P. Kotlarczyk, Subashan Perera, Neil M. Resnick, and David A. Nace declare that they have no conflict of interest. Susan L. Greenspan has received research grant support from Amgen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving human participants were in accordance with the ethical standards of the University of Pittsburgh institutional review board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained for all participants in the main study as previously indicated [].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"79"}}